Back to Search Start Over

Integron detection for prediction of trimethoprim/sulfamethoxazole susceptibility in children with Enterobacterales urinary tract infections.

Authors :
Elias, Peter
Barraud, Olivier
Hamel, Chahrazed El
Chainier, Delphine
Dallochio, Aymeric
Grélaud, Carole
Ploy, Marie-Cécile
Guigonis, Vincent
Garnier, Fabien
El Hamel, Chahrazed
Source :
Journal of Antimicrobial Chemotherapy (JAC); Mar2022, Vol. 77 Issue 3, p767-770, 4p
Publication Year :
2022

Abstract

<bold>Objectives: </bold>In some countries, third-generation cephalosporins (3GCs) serve as first-line therapy in children with urinary tract infections (UTIs). However, their use may contribute to the emergence of antibiotic resistance, notably among Gram-negative bacteria (GNB). Integrons are bacterial genetic elements involved in antibiotic resistance in GNB. Their absence is associated with >97% susceptibility to trimethoprim/sulfamethoxazole in adults infected with GNB. The objective of this study was to examine the value of integron detection directly from urine samples as a predictive marker of resistance to trimethoprim/sulfamethoxazole in children with GNB-related UTIs.<bold>Methods: </bold>Children admitted to the Limoges University Hospital's paediatric emergency department between February 2018 and March 2019 with a suspicion of UTI were eligible for the study. Only confirmed cases presenting a positive urine culture with unique GNB were retained for further study analyses. Integrons were detected directly from urines using real-time PCR.<bold>Results: </bold>The data of 72 patients were analysed and integrons were detected in 15 urine samples. The negative predictive value of integron detection for resistance to trimethoprim/sulfamethoxazole was 100% as all of the GNB (all were Enterobacterales) isolated from patients with no integrons detected in their urine samples were susceptible to trimethoprim/sulfamethoxazole.<bold>Conclusions: </bold>The detection of integrons in cases of paediatric patients with suspected UTI could help limit 3GC empirical use and empower an empirical first-line strategy better tailored to the needs of each patient. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03057453
Volume :
77
Issue :
3
Database :
Complementary Index
Journal :
Journal of Antimicrobial Chemotherapy (JAC)
Publication Type :
Academic Journal
Accession number :
155403927
Full Text :
https://doi.org/10.1093/jac/dkab431